Helaina

New York, United States

Helaina is a biotechnology company that focuses on advanced nutrition through the replication of functional proteins.

$45.0M raised

Sep 2024

Series B

Top Investors

Primary Venture PartnersSpark CapitalPlum AlleyAvidity PartnersCosmic Venture Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Helaina raised?

Helaina has raised $45.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.

Who are Helaina's investors?

Helaina's investors include Primary Venture Partners, Spark Capital, Plum Alley, Avidity Partners, Cosmic Venture Partners.

Where is Helaina headquartered?

Helaina is headquartered in New York, United States.

What does Helaina do?

Helaina is a biotechnology company that focuses on advanced nutrition through the replication of functional proteins.

What stage is Helaina at?

Helaina is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 25, 2024.

MLA

"Helaina — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/helaina. Accessed June 4, 2026.

APA

VCBacked. (2024). Helaina — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/helaina

Wikipedia (cite web)

{{cite web |title=Helaina — Funding & Investors |url=https://www.vcbacked.co/company/helaina |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 25, 2024.